Immunophenotyping in pemphigus reveals a TH17/TFH17 cell–dominated immune response promoting desmoglein1/3-specific autoantibody production
Julia Holstein(University of Tübingen), Christian Möbs(Philipps University of Marburg), Rüdiger Eming(Philipps University of Marburg), Katharina Meier(Humboldt-Universität zu Berlin), Alexandra Polakova(Philipps University of Marburg), Michael Hertl(Universitätsklinikum Gießen und Marburg), Dario Didona(Istituto Dermopatico dell'Immacolata), Amir S. Yazdi(Universitätsklinikum Aachen), Tobias Tekath(University of Münster), Nicolas Casadei(Bernstein Center for Computational Neuroscience Tübingen), Farzan Solimani(Humboldt-Universität zu Berlin), Kamran Ghoreschi(National Institutes of Health), Carolin Baum(Philipps University of Marburg), Robert Pollmann(Philipps University of Marburg), Iris Schäfer(University of Tübingen), Wolfgang Pfützner(Philipps University of Marburg), Martin Dugas(University of Münster), Jakob Matthes(University of Tübingen), Christoph Hudemann(Philipps University of Marburg)
Cited by 95
Related Papers
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
|The Journal of Immunology|2011|634
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|379